Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion type Assertion NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_head.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion description "[Favorable neuroblastoma genes (EPHB6, EFNB2, EFNB3, NTRK1, and CD44) are genes whose high-level expression predicts favorable neuroblastoma disease outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_provenance.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion evidence source_evidence_literature NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_provenance.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion SIO_000772 17947461 NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_provenance.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion wasDerivedFrom befree-20140225 NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_provenance.
- NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_assertion wasGeneratedBy ECO_0000203 NP162563.RABd0d7ee_AA7t3YFci5AGDIsbI0L9bUWq8IhpulDMRJA130_provenance.